Acute On Chronic Liver Failure Market - Global Outlook and Forecast 2021-2027

April 2021 | 92 pages | ID: A5A575029CC5EN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Acute On Chronic Liver Failure in Global, including the following market information:

Global Acute On Chronic Liver Failure Market Revenue, 2016-2021, 2022-2027, ($ millions)

Global top five companies in 2020 (%)

The global Acute On Chronic Liver Failure market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Acute On Chronic Liver Failure companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Acute On Chronic Liver Failure Market, By Type, 2016-2021, 2022-2027 ($ millions)

Global Acute On Chronic Liver Failure Market Segment Percentages, By Type, 2020 (%)

• Surgery
• Medication
• Others

China Acute On Chronic Liver Failure Market, By Application, 2016-2021, 2022-2027 ($ millions)

China Acute On Chronic Liver Failure Market Segment Percentages, By Application, 2020 (%)

• Hospital
• Clinic
• Others

Global Acute On Chronic Liver Failure Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)

Global Acute On Chronic Liver Failure Market Segment Percentages, By Region and Country, 2020 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Total Acute On Chronic Liver Failure Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)

Total Acute On Chronic Liver Failure Market Competitors Revenues Share in Global, by Players 2020 (%)

Further, the report presents profiles of competitors in the market, including the following:

• Grifols Therapeutics
• Promethera Biosciences
• RHEACELL
• Versantis AG
• Martin pharmaceuticals

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Congenital Hyperinsulinism Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Congenital Hyperinsulinism Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL CONGENITAL HYPERINSULINISM OVERALL MARKET SIZE

2.1 Global Congenital Hyperinsulinism Market Size: 2021 VS 2027
2.2 Global Congenital Hyperinsulinism Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Congenital Hyperinsulinism Players in Global Market
3.2 Top Global Congenital Hyperinsulinism Companies Ranked by Revenue
3.3 Global Congenital Hyperinsulinism Revenue by Companies
3.4 Top 3 and Top 5 Congenital Hyperinsulinism Companies in Global Market, by Revenue in 2020
3.5 Global Companies Congenital Hyperinsulinism Product Type
3.6 Tier 1, Tier 2 and Tier 3 Congenital Hyperinsulinism Players in Global Market
  3.6.1 List of Global Tier 1 Congenital Hyperinsulinism Companies
  3.6.2 List of Global Tier 2 and Tier 3 Congenital Hyperinsulinism Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Congenital Hyperinsulinism Market Size Markets, 2021 & 2027
  4.1.2 Surgery
  4.1.3 Medication
  4.1.4 Others
4.2 By Type - Global Congenital Hyperinsulinism Revenue & Forecasts
  4.2.1 By Type - Global Congenital Hyperinsulinism Revenue, 2016-2021
  4.2.2 By Type - Global Congenital Hyperinsulinism Revenue, 2022-2027
  4.2.3 By Type - Global Congenital Hyperinsulinism Revenue Market Share, 2016-2027

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Congenital Hyperinsulinism Market Size, 2021 & 2027
  5.1.2 Hospital
  5.1.3 Clinic
  5.1.4 Others
5.2 By Application - Global Congenital Hyperinsulinism Revenue & Forecasts
  5.2.1 By Application - Global Congenital Hyperinsulinism Revenue, 2016-2021
  5.2.2 By Application - Global Congenital Hyperinsulinism Revenue, 2022-2027
  5.2.3 By Application - Global Congenital Hyperinsulinism Revenue Market Share, 2016-2027

6 SIGHTS BY REGION

6.1 By Region - Global Congenital Hyperinsulinism Market Size, 2021 & 2027
6.2 By Region - Global Congenital Hyperinsulinism Revenue & Forecasts
  6.2.1 By Region - Global Congenital Hyperinsulinism Revenue, 2016-2021
  6.2.2 By Region - Global Congenital Hyperinsulinism Revenue, 2022-2027
  6.2.3 By Region - Global Congenital Hyperinsulinism Revenue Market Share, 2016-2027
6.3 North America
  6.3.1 By Country - North America Congenital Hyperinsulinism Revenue, 2016-2027
  6.3.2 US Congenital Hyperinsulinism Market Size, 2016-2027
  6.3.3 Canada Congenital Hyperinsulinism Market Size, 2016-2027
  6.3.4 Mexico Congenital Hyperinsulinism Market Size, 2016-2027
6.4 Europe
  6.4.1 By Country - Europe Congenital Hyperinsulinism Revenue, 2016-2027
  6.4.2 Germany Congenital Hyperinsulinism Market Size, 2016-2027
  6.4.3 France Congenital Hyperinsulinism Market Size, 2016-2027
  6.4.4 U.K. Congenital Hyperinsulinism Market Size, 2016-2027
  6.4.5 Italy Congenital Hyperinsulinism Market Size, 2016-2027
  6.4.6 Russia Congenital Hyperinsulinism Market Size, 2016-2027
  6.4.7 Nordic Countries Congenital Hyperinsulinism Market Size, 2016-2027
  6.4.8 Benelux Congenital Hyperinsulinism Market Size, 2016-2027
6.5 Asia
  6.5.1 By Region - Asia Congenital Hyperinsulinism Revenue, 2016-2027
  6.5.2 China Congenital Hyperinsulinism Market Size, 2016-2027
  6.5.3 Japan Congenital Hyperinsulinism Market Size, 2016-2027
  6.5.4 South Korea Congenital Hyperinsulinism Market Size, 2016-2027
  6.5.5 Southeast Asia Congenital Hyperinsulinism Market Size, 2016-2027
  6.5.6 India Congenital Hyperinsulinism Market Size, 2016-2027
6.6 South America
  6.6.1 By Country - South America Congenital Hyperinsulinism Revenue, 2016-2027
  6.6.2 Brazil Congenital Hyperinsulinism Market Size, 2016-2027
  6.6.3 Argentina Congenital Hyperinsulinism Market Size, 2016-2027
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Congenital Hyperinsulinism Revenue, 2016-2027
  6.7.2 Turkey Congenital Hyperinsulinism Market Size, 2016-2027
  6.7.3 Israel Congenital Hyperinsulinism Market Size, 2016-2027
  6.7.4 Saudi Arabia Congenital Hyperinsulinism Market Size, 2016-2027
  6.7.5 UAE Congenital Hyperinsulinism Market Size, 2016-2027

7 PLAYERS PROFILES

7.1 IVAX Pharmaceuticals
  7.1.1 IVAX Pharmaceuticals Corporate Summary
  7.1.2 IVAX Pharmaceuticals Business Overview
  7.1.3 IVAX Pharmaceuticals Congenital Hyperinsulinism Major Product Offerings
  7.1.4 IVAX Pharmaceuticals Congenital Hyperinsulinism Revenue in Global (2016-2021)
  7.1.5 IVAX Pharmaceuticals Key News
7.2 Teva Pharmaceuticals
  7.2.1 Teva Pharmaceuticals Corporate Summary
  7.2.2 Teva Pharmaceuticals Business Overview
  7.2.3 Teva Pharmaceuticals Congenital Hyperinsulinism Major Product Offerings
  7.2.4 Teva Pharmaceuticals Congenital Hyperinsulinism Revenue in Global (2016-2021)
  7.2.5 Teva Pharmaceuticals Key News
7.3 Zealand Pharma
  7.3.1 Zealand Pharma Corporate Summary
  7.3.2 Zealand Pharma Business Overview
  7.3.3 Zealand Pharma Congenital Hyperinsulinism Major Product Offerings
  7.3.4 Zealand Pharma Congenital Hyperinsulinism Revenue in Global (2016-2021)
  7.3.5 Zealand Pharma Key News
7.4 Rezolute
  7.4.1 Rezolute Corporate Summary
  7.4.2 Rezolute Business Overview
  7.4.3 Rezolute Congenital Hyperinsulinism Major Product Offerings
  7.4.4 Rezolute Congenital Hyperinsulinism Revenue in Global (2016-2021)
  7.4.5 Rezolute Key News
7.5 Xeris Pharmaceuticals
  7.5.1 Xeris Pharmaceuticals Corporate Summary
  7.5.2 Xeris Pharmaceuticals Business Overview
  7.5.3 Xeris Pharmaceuticals Congenital Hyperinsulinism Major Product Offerings
  7.5.4 Xeris Pharmaceuticals Congenital Hyperinsulinism Revenue in Global (2016-2021)
  7.5.5 Xeris Pharmaceuticals Key News
7.6 Eiger BioPharmaceuticals
  7.6.1 Eiger BioPharmaceuticals Corporate Summary
  7.6.2 Eiger BioPharmaceuticals Business Overview
  7.6.3 Eiger BioPharmaceuticals Congenital Hyperinsulinism Major Product Offerings
  7.6.4 Eiger BioPharmaceuticals Congenital Hyperinsulinism Revenue in Global (2016-2021)
  7.6.5 Eiger BioPharmaceuticals Key News
7.7 AmideBio
  7.7.1 AmideBio Corporate Summary
  7.7.2 AmideBio Business Overview
  7.7.3 AmideBio Congenital Hyperinsulinism Major Product Offerings
  7.4.4 AmideBio Congenital Hyperinsulinism Revenue in Global (2016-2021)
  7.7.5 AmideBio Key News
7.8 Recordati
  7.8.1 Recordati Corporate Summary
  7.8.2 Recordati Business Overview
  7.8.3 Recordati Congenital Hyperinsulinism Major Product Offerings
  7.8.4 Recordati Congenital Hyperinsulinism Revenue in Global (2016-2021)
  7.8.5 Recordati Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Acute On Chronic Liver Failure Market Opportunities & Trends in Global Market
Table 2. Acute On Chronic Liver Failure Market Drivers in Global Market
Table 3. Acute On Chronic Liver Failure Market Restraints in Global Market
Table 4. Key Players of Acute On Chronic Liver Failure in Global Market
Table 5. Top Acute On Chronic Liver Failure Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Acute On Chronic Liver Failure Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Acute On Chronic Liver Failure Revenue Share by Companies, 2016-2021
Table 8. Global Companies Acute On Chronic Liver Failure Product Type
Table 9. List of Global Tier 1 Acute On Chronic Liver Failure Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Acute On Chronic Liver Failure Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type – Global Acute On Chronic Liver Failure Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Acute On Chronic Liver Failure Revenue in Global (US$, Mn), 2016-2021
Table 13. By Type - Acute On Chronic Liver Failure Revenue in Global (US$, Mn), 2022-2027
Table 14. By Application – Global Acute On Chronic Liver Failure Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - Acute On Chronic Liver Failure Revenue in Global (US$, Mn), 2016-2021
Table 16. By Application - Acute On Chronic Liver Failure Revenue in Global (US$, Mn), 2022-2027
Table 17. By Region – Global Acute On Chronic Liver Failure Revenue, (US$, Mn), 2021 VS 2027
Table 18. By Region - Global Acute On Chronic Liver Failure Revenue (US$, Mn), 2016-2021
Table 19. By Region - Global Acute On Chronic Liver Failure Revenue (US$, Mn), 2022-2027
Table 20. By Country - North America Acute On Chronic Liver Failure Revenue, (US$, Mn), 2016-2021
Table 21. By Country - North America Acute On Chronic Liver Failure Revenue, (US$, Mn), 2022-2027
Table 22. By Country - Europe Acute On Chronic Liver Failure Revenue, (US$, Mn), 2016-2021
Table 23. By Country - Europe Acute On Chronic Liver Failure Revenue, (US$, Mn), 2022-2027
Table 24. By Region - Asia Acute On Chronic Liver Failure Revenue, (US$, Mn), 2016-2021
Table 25. By Region - Asia Acute On Chronic Liver Failure Revenue, (US$, Mn), 2022-2027
Table 26. By Country - South America Acute On Chronic Liver Failure Revenue, (US$, Mn), 2016-2021
Table 27. By Country - South America Acute On Chronic Liver Failure Revenue, (US$, Mn), 2022-2027
Table 28. By Country - Middle East & Africa Acute On Chronic Liver Failure Revenue, (US$, Mn), 2016-2021
Table 29. By Country - Middle East & Africa Acute On Chronic Liver Failure Revenue, (US$, Mn), 2022-2027
Table 30. Grifols Therapeutics Corporate Summary
Table 31. Grifols Therapeutics Acute On Chronic Liver Failure Product Offerings
Table 32. Grifols Therapeutics Acute On Chronic Liver Failure Revenue (US$, Mn), (2016-2021)
Table 33. Promethera Biosciences Corporate Summary
Table 34. Promethera Biosciences Acute On Chronic Liver Failure Product Offerings
Table 35. Promethera Biosciences Acute On Chronic Liver Failure Revenue (US$, Mn), (2016-2021)
Table 36. RHEACELL Corporate Summary
Table 37. RHEACELL Acute On Chronic Liver Failure Product Offerings
Table 38. RHEACELL Acute On Chronic Liver Failure Revenue (US$, Mn), (2016-2021)
Table 39. Versantis AG Corporate Summary
Table 40. Versantis AG Acute On Chronic Liver Failure Product Offerings
Table 41. Versantis AG Acute On Chronic Liver Failure Revenue (US$, Mn), (2016-2021)
Table 42. Martin pharmaceuticals Corporate Summary
Table 43. Martin pharmaceuticals Acute On Chronic Liver Failure Product Offerings
Table 44. Martin pharmaceuticals Acute On Chronic Liver Failure Revenue (US$, Mn), (2016-2021)

List Of Figures

LIST OF FIGURES

Figure 1. Acute On Chronic Liver Failure Segment by Type
Figure 2. Acute On Chronic Liver Failure Segment by Application
Figure 3. Global Acute On Chronic Liver Failure Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Acute On Chronic Liver Failure Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Acute On Chronic Liver Failure Revenue, 2016-2027 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Acute On Chronic Liver Failure Revenue in 2020
Figure 8. By Type - Global Acute On Chronic Liver Failure Revenue Market Share, 2016-2027
Figure 9. By Application - Global Acute On Chronic Liver Failure Revenue Market Share, 2016-2027
Figure 10. By Region - Global Acute On Chronic Liver Failure Revenue Market Share, 2016-2027
Figure 11. By Country - North America Acute On Chronic Liver Failure Revenue Market Share, 2016-2027
Figure 12. US Acute On Chronic Liver Failure Revenue, (US$, Mn), 2016-2027
Figure 13. Canada Acute On Chronic Liver Failure Revenue, (US$, Mn), 2016-2027
Figure 14. Mexico Acute On Chronic Liver Failure Revenue, (US$, Mn), 2016-2027
Figure 15. By Country - Europe Acute On Chronic Liver Failure Revenue Market Share, 2016-2027
Figure 16. Germany Acute On Chronic Liver Failure Revenue, (US$, Mn), 2016-2027
Figure 17. France Acute On Chronic Liver Failure Revenue, (US$, Mn), 2016-2027
Figure 18. U.K. Acute On Chronic Liver Failure Revenue, (US$, Mn), 2016-2027
Figure 19. Italy Acute On Chronic Liver Failure Revenue, (US$, Mn), 2016-2027
Figure 20. Russia Acute On Chronic Liver Failure Revenue, (US$, Mn), 2016-2027
Figure 21. Nordic Countries Acute On Chronic Liver Failure Revenue, (US$, Mn), 2016-2027
Figure 22. Benelux Acute On Chronic Liver Failure Revenue, (US$, Mn), 2016-2027
Figure 23. By Region - Asia Acute On Chronic Liver Failure Revenue Market Share, 2016-2027
Figure 24. China Acute On Chronic Liver Failure Revenue, (US$, Mn), 2016-2027
Figure 25. Japan Acute On Chronic Liver Failure Revenue, (US$, Mn), 2016-2027
Figure 26. South Korea Acute On Chronic Liver Failure Revenue, (US$, Mn), 2016-2027
Figure 27. Southeast Asia Acute On Chronic Liver Failure Revenue, (US$, Mn), 2016-2027
Figure 28. India Acute On Chronic Liver Failure Revenue, (US$, Mn), 2016-2027
Figure 29. By Country - South America Acute On Chronic Liver Failure Revenue Market Share, 2016-2027
Figure 30. Brazil Acute On Chronic Liver Failure Revenue, (US$, Mn), 2016-2027
Figure 31. Argentina Acute On Chronic Liver Failure Revenue, (US$, Mn), 2016-2027
Figure 32. By Country - Middle East & Africa Acute On Chronic Liver Failure Revenue Market Share, 2016-2027
Figure 33. Turkey Acute On Chronic Liver Failure Revenue, (US$, Mn), 2016-2027
Figure 34. Israel Acute On Chronic Liver Failure Revenue, (US$, Mn), 2016-2027
Figure 35. Saudi Arabia Acute On Chronic Liver Failure Revenue, (US$, Mn), 2016-2027
Figure 36. UAE Acute On Chronic Liver Failure Revenue, (US$, Mn), 2016-2027
Figure 37. Grifols Therapeutics Acute On Chronic Liver Failure Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. Promethera Biosciences Acute On Chronic Liver Failure Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. RHEACELL Acute On Chronic Liver Failure Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. Versantis AG Acute On Chronic Liver Failure Revenue Year Over Year Growth (US$, Mn) & (2016-2021)